 Article
Feeds
|
Latent Impact of Corporate Government Reforms on Biotechnology Companies |
June 1, 2004
Previously published on April 2003
Private companies are beginning to experience lessons that the public company sector learned six months ago. The reach of corporate governance reforms in the wake of Enron, WorldCom, and other corporate scandals -- while focused on public companies and capital markets -- extends long and deep.
|
The views expressed in this article are solely the views of the author and not Martindale-Hubbell. This article is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance. |
|
|
RSS | Blogs | Site Map | Contact Us